FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285403731> ?p ?o ?g. }

• W4285403731 abstract "Evaluating the use of antibiotics leads to identifying drug problems, preventing antibiotic resistance, and controlling the cost of medication. The aim of this study was to Drug Utilization Evaluation (DUE) of vancomycin. This study was a descriptive retrospective cross-sectional study. Sampling method was the census. The information was collected through a checklist and referring to patients' files. 170 children and 120 adults who received vancomycin were studied. The dose of vancomycin in the studied adults was 40.6% and 61% was in accordance with the Uptodate guideline. Also, the duration of treatment in the studied children was 10.6% and 15.3% according to the Uptodate guideline and in adults 30%, 39.2% was in accordance with the Uptodate guideline. Also, the indication for vancomycin in children was 14.1% and 18.8% in accordance with the Uptodate guideline, and in adults 40% and 52.5% was in accordance with the Uptodate guideline. The highest initial diagnosis in children was RDS 54.1%, seizure 9.4%, jaundice 9.4% and pneumonia 8.2%, and in adults 30% CRF and 11.7% catheter. In children, the most common complications were related to shortness of breath 41.2%, fever 18.8% and jaundice 11.8%, and in adults were related to fever 32.5%, lethargy 26.7% and shortness of breath 20%, respectively. It is recommended to improve the administration and rational use of antibiotics and prevent the occurrence of microbial resistance, to follow the treatment patterns based on international standards in hospitals." @default.
• W4285403731 created "2022-07-14" @default.
• W4285403731 creator A5006760614 @default.
• W4285403731 creator A5024032807 @default.
• W4285403731 creator A5034461757 @default.
• W4285403731 creator A5050175917 @default.
• W4285403731 creator A5089468636 @default.
• W4285403731 date "2022-08-01" @default.
• W4285403731 modified "2023-09-25" @default.
• W4285403731 title "Drug Utilization Evaluation (DUE) of vancomycin: A cross-sectional study" @default.
• W4285403731 cites W1722939062 @default.
• W4285403731 cites W1762461404 @default.
• W4285403731 cites W1978483118 @default.
• W4285403731 cites W2036943934 @default.
• W4285403731 cites W2045803206 @default.
• W4285403731 cites W2100707382 @default.
• W4285403731 cites W2612865085 @default.
• W4285403731 cites W2807383272 @default.
• W4285403731 cites W2911498313 @default.
• W4285403731 cites W2935164816 @default.
• W4285403731 cites W2972725817 @default.
• W4285403731 cites W2975733401 @default.
• W4285403731 cites W2978820669 @default.
• W4285403731 cites W2998110188 @default.
• W4285403731 cites W3005744162 @default.
• W4285403731 cites W3006445303 @default.
• W4285403731 cites W3013573895 @default.
• W4285403731 cites W3024119572 @default.
• W4285403731 cites W3212282753 @default.
• W4285403731 cites W4230383949 @default.
• W4285403731 doi "https://doi.org/10.1016/j.amsu.2022.104169" @default.
• W4285403731 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36045798" @default.
• W4285403731 hasPublicationYear "2022" @default.
• W4285403731 type Work @default.
• W4285403731 citedByCount "0" @default.
• W4285403731 crossrefType "journal-article" @default.
• W4285403731 hasAuthorship W4285403731A5006760614 @default.
• W4285403731 hasAuthorship W4285403731A5024032807 @default.
• W4285403731 hasAuthorship W4285403731A5034461757 @default.
• W4285403731 hasAuthorship W4285403731A5050175917 @default.
• W4285403731 hasAuthorship W4285403731A5089468636 @default.
• W4285403731 hasBestOaLocation W42854037311 @default.
• W4285403731 hasConcept C126322002 @default.
• W4285403731 hasConcept C142052008 @default.
• W4285403731 hasConcept C142724271 @default.
• W4285403731 hasConcept C15744967 @default.
• W4285403731 hasConcept C177713679 @default.
• W4285403731 hasConcept C180747234 @default.
• W4285403731 hasConcept C187212893 @default.
• W4285403731 hasConcept C194828623 @default.
• W4285403731 hasConcept C2777179404 @default.
• W4285403731 hasConcept C2777914695 @default.
• W4285403731 hasConcept C2778456037 @default.
• W4285403731 hasConcept C2778980435 @default.
• W4285403731 hasConcept C2779356329 @default.
• W4285403731 hasConcept C2779489039 @default.
• W4285403731 hasConcept C2780035454 @default.
• W4285403731 hasConcept C2780182762 @default.
• W4285403731 hasConcept C501593827 @default.
• W4285403731 hasConcept C523546767 @default.
• W4285403731 hasConcept C54355233 @default.
• W4285403731 hasConcept C71924100 @default.
• W4285403731 hasConcept C86803240 @default.
• W4285403731 hasConcept C89423630 @default.
• W4285403731 hasConcept C98274493 @default.
• W4285403731 hasConceptScore W4285403731C126322002 @default.
• W4285403731 hasConceptScore W4285403731C142052008 @default.
• W4285403731 hasConceptScore W4285403731C142724271 @default.
• W4285403731 hasConceptScore W4285403731C15744967 @default.
• W4285403731 hasConceptScore W4285403731C177713679 @default.
• W4285403731 hasConceptScore W4285403731C180747234 @default.
• W4285403731 hasConceptScore W4285403731C187212893 @default.
• W4285403731 hasConceptScore W4285403731C194828623 @default.
• W4285403731 hasConceptScore W4285403731C2777179404 @default.
• W4285403731 hasConceptScore W4285403731C2777914695 @default.
• W4285403731 hasConceptScore W4285403731C2778456037 @default.
• W4285403731 hasConceptScore W4285403731C2778980435 @default.
• W4285403731 hasConceptScore W4285403731C2779356329 @default.
• W4285403731 hasConceptScore W4285403731C2779489039 @default.
• W4285403731 hasConceptScore W4285403731C2780035454 @default.
• W4285403731 hasConceptScore W4285403731C2780182762 @default.
• W4285403731 hasConceptScore W4285403731C501593827 @default.
• W4285403731 hasConceptScore W4285403731C523546767 @default.
• W4285403731 hasConceptScore W4285403731C54355233 @default.
• W4285403731 hasConceptScore W4285403731C71924100 @default.
• W4285403731 hasConceptScore W4285403731C86803240 @default.
• W4285403731 hasConceptScore W4285403731C89423630 @default.
• W4285403731 hasConceptScore W4285403731C98274493 @default.
• W4285403731 hasLocation W42854037311 @default.
• W4285403731 hasLocation W42854037312 @default.
• W4285403731 hasLocation W42854037313 @default.
• W4285403731 hasOpenAccess W4285403731 @default.
• W4285403731 hasPrimaryLocation W42854037311 @default.
• W4285403731 hasRelatedWork W2092505418 @default.
• W4285403731 hasRelatedWork W2162788500 @default.
• W4285403731 hasRelatedWork W2184432704 @default.
• W4285403731 hasRelatedWork W2247376599 @default.
• W4285403731 hasRelatedWork W2409546295 @default.
• W4285403731 hasRelatedWork W2810720844 @default.
• W4285403731 hasRelatedWork W2954102542 @default.

• next